Candel Therapeutics, Inc. ( CADL) - Stock Earnings

CADL Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2026Q1 -8.9 million USD — USD
2026Q2 -38.9 million USD — USD
2026Q3 -21.9 million USD — USD
2026Q4 Est. — —
2027Q1 Est. — —
2027Q2 Est. — —

CADL Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -37.9 million USD 31000 USD
2024 -55.2 million USD — USD
2025 -38.2 million USD — USD
2026 Est. — —

CADL

Price: $4.96

52 week price:
4.35
14.00

Earnings Per Share: -1.53 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 14500

Market Capitalization: 423.6 million

Links: